Your browser doesn't support javascript.
loading
REduced-Carbohydrate intervention for managing Obesity and Reduction of gestational Diabetes (RECORD): A randomized controlled feasibility trial.
Michalopoulou, Moscho; Jebb, Susan A; MacKillop, Lucy H; Dyson, Pamela; Hirst, Jane E; Zhu, Sufen; Wire, Amy; Astbury, Nerys M.
Afiliação
  • Michalopoulou M; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • Jebb SA; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • MacKillop LH; Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.
  • Dyson P; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Hirst JE; Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), University of Oxford, Oxford, UK.
  • Zhu S; Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.
  • Wire A; The George Institute for Global Health, Imperial College London, London, UK.
  • Astbury NM; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Diabetes Obes Metab ; 26(4): 1407-1420, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38229418
ABSTRACT

AIM:

To test the feasibility and acceptability of a reduced-carbohydrate dietary program, intended to reduce the risk of gestational diabetes. MATERIALS AND

METHODS:

Fifty-one pregnant women at <20 weeks' gestation, with body mass index ≥30 kg/m2 , and a normal baseline oral glucose tolerance test (OGTT), were randomized 21 to an intervention or control group and followed-up until delivery. The dietary intervention aimed at providing 130-150 g carbohydrate/day. Feasibility outcomes assessed at 24-28 weeks' gestation, included adoption of the reduced-carbohydrate diet by the intervention group, and retention of all participants, assessed by completion of a second OGTT. Changes in glycemia, weight gain and dietary intake, and the maternal and neonatal outcomes were also assessed. Participants were interviewed about their experience of the intervention and the study.

RESULTS:

Forty-nine of 51 participants attended the follow-up OGTT, a retention rate of 96% (95% confidence interval [CI] 86.8%-98.9%). In the intervention group, carbohydrate intake at follow-up was 190.4 (95% CI 162.5-215.6) g/day, a reduction of -24.6 (95% CI -51.5-2.4) g/day from baseline. Potentially favourable effects of the intervention on glucose control, weight gain and blood pressure were observed, but the study was not powered to detect significant differences in these. Participants found the intervention acceptable, and were content with the study processes, but some reported barriers to sustained adherence, mainly pertaining to competing priorities.

CONCLUSIONS:

Retention was high, suggesting the study processes are feasible, but the carbohydrate reduction in the intervention group was small, and did not meet progression criteria, limiting the likelihood of achieving the desired goal to prevent gestational diabetes. TRIAL REGISTRATION NUMBER ISRCTN16235884.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Gestacional Tipo de estudo: Clinical_trials Limite: Female / Humans / Newborn / Pregnancy Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Gestacional Tipo de estudo: Clinical_trials Limite: Female / Humans / Newborn / Pregnancy Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2024 Tipo de documento: Article